BluePath Capital Management’s Merck MRK Stock Holding History

BluePath Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.79M	Buy	12,343 +1,950	+19%	+$269K	0.94%	28
2026 Q2	$1.34M	Sell	10,393 -652	-6%	-$76.3K	0.73%	40
2026 Q1	$1.33M	Buy	+11,045	New	+$1.28M	0.92%	27
2024 Q4	–	Sell	-8,426	Closed	-$957K	–	108
2024 Q3	$957K	Buy	8,426 +1,728	+26%	+$205K	0.59%	37
2024 Q2	$829K	Buy	6,698 +1,297	+24%	+$167K	0.58%	38
2024 Q1	$713K	Buy	5,401 +940	+21%	+$116K	0.54%	30
2023 Q4	$530K	Buy	4,461 +940	+27%	+$97.6K	0.45%	53
2023 Q3	$363K	Buy	+3,521	New	+$380K	0.33%	62

Other funds holding MRK

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

BluePath Capital Management's MRK Position: Q3 2026 in Review

BluePath Capital Management increased its Merck (MRK) stake by 19% in Q3 2026, buying an estimated $269K and bringing the position to 12,343 shares worth $1.79M. The position accounts for 0.94% of the portfolio, ranked #28.

BluePath Capital Management first reported a position in MRK in Q3 2023 and has held it in 8 quarters since. 1,488 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

BluePath Capital Management held 12,343 shares of Merck worth $1.79M as of Q3 2026.
BluePath Capital Management bought 1,950 Merck shares in Q3 2026, an estimated $269K.
Merck made up 0.94% of BluePath Capital Management's portfolio in Q3 2026, its #28 holding.
BluePath Capital Management first reported a position in Merck in Q3 2023 and has held it in 8 quarters since.
1,488 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.